ArticleFrontiers in endocrinology2026
Longitudinal outcomes associated with structured exercise and dietary and microbiota-targeted care in patients with diabetic sarcopenia: a retrospective cohort study.
Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Diabetic sarcopenia is associated with functional impairment and metabolic abnormalities in patients with type 2 diabetes mellitus (T2DM). Real-world evidence regarding structured exercise combined with dietary and microbiota-targeted care remains limited. Methods: This retrospective cohort study included 128 patients with T2DM and sarcopenia between January 2022 and December 2024. Based on the treatment received, patients were divided into a control group receiving conventional diabetes management (n = 63) and an intervention group receiving conventional management combined with structured exercise, dietary and microbiota-targeted care (n = 65). Outcomes were assessed at baseline and months 1, 3, 6, 9, and 12. The primary outcome was the longitudinal change in skeletal muscle index (SMI). Secondary outcomes included handgrip strength, gait speed, Short Physical Performance Battery (SPPB) score, glycated hemoglobin A1c (HbA1c), fasting plasma glucose (FPG), and homeostasis model assessment of insulin resistance (HOMA-IR), as well as the incidence of adverse events. Adjusted generalized estimating equation models were used to evaluate longitudinal trajectories. Results: Significant group × time interactions were observed for SMI (P = 0.017), handgrip strength (P < 0.001), gait speed (P < 0.001), and SPPB score (P = 0.015). At month 12, adjusted between-group differences favoring the intervention group were 0.282 kg/m² for SMI (95% CI, 0.177-0.387), 3.348 kg for handgrip strength (95% CI, 2.718-3.983), 0.129 m/s for gait speed (95% CI, 0.109-0.149), and 1.225 points for SPPB score (95% CI, 0.895-1.556; all P < 0.001). Group × time interactions were not significant for HbA1c, HOMA-IR, or FPG. No significant difference in adverse-event incidence was detected (Risk ratio: 1.171; P = 0.478). Conclusions: Structured exercise combined with dietary and microbiota-targeted care was associated with more favorable muscle-related trajectories but not superior overall glycemic control. The observational design precludes causal inference or separation of individual component effects, warranting confirmation in prospective randomized trials.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.